Fiche société
Exciva GmbH
Traitements, essais et publications liés.
Traitements3programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| EXV-801The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia. | Alzheimer | Phase 2/3 | À vérifier | United States, Canada, Czechia, Germany, Italy, Poland, Slovakia, Spain, … | À vérifier |
| EXV-802The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia. | Alzheimer | Phase 2/3 | À vérifier | United States, Canada, Czechia, Germany, Italy, Poland, Slovakia, Spain, … | À vérifier |
| EXV-802The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia. | Alzheimer | Phase 2/3 | À vérifier | United States, Canada, Czechia, Germany, Italy, Poland, Slovakia, Spain, United Kingdom | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| EXV-802 | Alzheimer | Phase 2/3 | NCT07284472 | SERENADA — Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia | RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||